Inhibitors of the Interaction Between Mdm2 and P53
申请人:Lacrampe Fernand Armand Jean
公开号:US20080039472A1
公开(公告)日:2008-02-14
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein n, m, p, s, t, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, X, Y, Q and Z have defined meanings.
Inhibitors of the Interaction Between MDM2 and P53
申请人:Lacrampe Jean Fernand Armand
公开号:US20110053937A1
公开(公告)日:2011-03-03
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein n, m, p, s, t, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, X, Y, Q and Z have defined meanings.
US7834016B2
申请人:——
公开号:US7834016B2
公开(公告)日:2010-11-16
US8404683B2
申请人:——
公开号:US8404683B2
公开(公告)日:2013-03-26
[EN] INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53<br/>[FR] INHIBITEURS DE L'INTERACTION ENTRE MDM2 ET P53
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006032631A1
公开(公告)日:2006-03-30
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, m, p, s, t, R1, R2, R3, R4, R5, R6, R7, X, Y, Q and Z have defined meanings.